Scimago Lab
powered by Scopus
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST


eISSN: 2329-0358

Home Page

Annals of Transplantation is one of the fast-developing journals open to all scientists and fields of transplant medicine and related research. The journal is published quarterly and provides extensive coverage of the most important advances in transplantation.
Using an electronic on-line submission and peer review tracking system, Annals of Transplantation is committed to rapid review and publication. The average time... read more

Published: 2019-08-20

Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study

Abdulahad Abdulrab Mohammed Al-Ameri, Xuyong Wei, Peng Liu, Lidan Lin, Zhou Shao, Haiyang Xie, Lin Zhou, Shusen Zheng, Xiao Xu

(Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China (mainland))

Ann Transplant 2019; 24:489-498

DOI: 10.12659/AOT.917296

BACKGROUND: Early recurrence after liver transplantation (LT) is still a clinical problem. This multicenter study evaluated the Milan, Hangzhou, and AFP model-based criteria for prediction of early recurrence of HCC in patients with cirrhosis who had undergone LT.
MATERIAL AND METHODS: From the China Liver Transplant Registry (CLTR) database, we analyzed data of 589 HCC patients who had undergone LT between Jan 2015 and Jan 2019. Imaging data and AFP levels were evaluated immediately before LT. Recurrence and overall survival rates at 2 years were tested using the Kaplan-Meier estimate. The Milan criteria, Hangzhou criteria, and AFP model-based criteria were evaluated.
RESULTS: We found that 62.0%, 91.2%, and 67.6% of patients were within the Milan criteria, Hangzhou criteria, and AFP model-based criteria, respectively. The 2-year recurrence rate was 8.9%, 15.8%, and 11.8% with corresponding overall survival of 85.3%, 82.7%, and 86.5%, respectively. The 2-year recurrence rate was different in patients fulfilling and exceeding the AFP model-based criteria among patients who met either the Milan criteria (7.9% vs. 18.8%, HR=3.83, p=0.006) or Hangzhou criteria (12.0% vs. 27.6%, HR=2.95, p<0.001). However, the 2-year recurrence rate was not significantly different among patients who were beyond either the Milan or Hangzhou criteria.
CONCLUSIONS: For the prediction of early recurrence of HCC in patients with cirrhosis after liver transplantation, Milan criteria, Hangzhou criteria, and AFP model-based criteria are effective predictive tools for stratification of patients into low- and high-risk groups of recurrence with different prognoses. The AFP model-based criteria can identify a subgroup of patients with high risk of recurrence among patients who met either Milan or Hangzhou criteria.

Keywords: Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Transplantation, Prognosis, Recurrence

Related Articles (0)

Coming Soon...

Published: 2019-08-16

Analysis of Data from the Oxygen Persufflation in Liver Transplantation (OPAL) Study to Determine the Rol...

Tamas Benkö, Jennifer Belker, Anja Gallinat, Jürgen W. Treckmann, Andreas Paul, Thomas Minor, Dieter P. Hoyer

Ann Transplant 2019; 24:481-488

DOI: 10.12659/AOT.915214

Published: 2019-08-13

Alloresponses of Mixed Lymphocyte Hepatocyte Culture to Immunosuppressive Drugs as an In-Vitro Model of ...

Felix Oldhafer, Eva-Maria Wittauer, Christine S. Falk, Daphne E. DeTemple, Oliver Beetz, Kai Timrott, Moritz Kleine, Florian W.R. Vondran

Ann Transplant 2019; 24:472-480

DOI: 10.12659/AOT.915982